Navigation path

Community Register of medicinal products

Community list of not active orphan medicinal products
WITHDRAWN  

Product information

Plitidepsin

EU orphan designation number: EU/3/10/839
Active ingredient: Plitidepsin
Indication: Treatment of post-polycythaemia vera myelofibrosis
Sponsor: Pharma Mar S.A. Sociedad Unipersonal
Avda de los Reyes 1, Polígono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/122/10 (2011)1305 of 23/02/2011
27/06/2011 Centralised Orphan - Removal of orphan designation from Community Register -